Business Context and Reporting Period
Community Health Systems, Inc. filed this Form 8-K on July 24, 2002, to announce operating results for the second quarter and six months ended June 30, 2002. The filing also provides updated financial guidance for the fiscal year ending December 31, 2002.
Key Financial Metrics and Guidance
The filing does not provide specific historical revenue, profit, or cash flow figures for the period ended June 30, 2002, referring instead to an attached press release (Exhibit 99.1). However, it provides the following forward-looking guidance for the full year 2002:
- Net Operating Revenue: $2,120 million to $2,150 million.
- EBITDA: $363 million to $367 million.
- Diluted EPS (Before Extraordinary Item): $0.97 to $1.01.
- Diluted Net Income Per Share: $0.92 to $0.96.
- Weighted Average Diluted Shares: 100 million to 101 million.
Quarterly Estimates for 2002
| Quarter | Diluted EPS (Before Extraordinary Item) | Diluted Net Income Per Share |
|---|---|---|
| 3rd Quarter (ending Sept 30, 2002) | $0.21 to $0.23 | $0.16 to $0.18 |
| 4th Quarter (ending Dec 31, 2002) | $0.25 to $0.27 | $0.25 to $0.27 |
Material Changes and Debt Refinancing
On July 16, 2002, the Company entered into a new $1.2 billion senior secured credit facility to refinance existing debt and fund general corporate purposes, including acquisitions. Key terms include:
- Term Loan: $850 million maturing in 2010 (extended from 2005).
- Revolving Credit: $350 million with a six-year term.
- Expansion Option: Feature allowing an additional $200 million in future funded term loans.
- Impact on Earnings: The Company expects to recognize an estimated $5.3 million after-tax extraordinary loss ($0.05 per diluted share) in the third quarter of 2002 due to the early extinguishment of debt and write-off of deferred financing costs.
The Company also utilizes three interest rate swap agreements (totaling $300 million notional) to hedge against interest rate fluctuations on long-term borrowings.
Accounting Changes and Risks
Effective January 1, 2002, the Company adopted SFAS No. 141 and SFAS No. 142. Consequently, 2002 guidance excludes non-cash goodwill amortization but includes amortization of other intangibles. This change results in an approximate $0.24 per share after-tax reduction in expense. No impairment write-downs are expected from this adoption.
Key Risks and Contingencies:
- Changes in Medicare and Medicaid payment levels.
- Legislative proposals for healthcare reform and regulatory compliance.
- Uncertainty regarding HIPAA regulations.
- Ability to attract and retain qualified personnel and physicians.
- Success in acquiring and integrating additional hospitals.
Investor Verification Checklist
- Verify the specific Q2 and six-month historical operating results in the attached Press Release (Exhibit 99.1), as they are not detailed in the 8-K text.
- Confirm the timing and exact amount of the $5.3 million extraordinary loss related to debt extinguishment in Q3 2002.
- Monitor the impact of the new $1.2 billion credit facility on future liquidity and interest expense.
- Assess the potential impact of healthcare reform legislation and changes in government reimbursement rates on the projected revenue range.
- Review the Company's ability to meet the weighted average diluted share count of 100-101 million, noting the exclusion of convertible note conversions in the guidance calculation.